• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Nicox broadens two agreements with Ocumension in South East Asia pharmaceutical-technology
    March 12, 2020
    France-headquartered Nicox has expanded two licensing agreements with Chinese Ocumension Therapeutics for two ophthalmology drugs.
  • Nicox signs agreement for ZERVIATE in South Korea biospectrumasia
    December 18, 2019
    Samil Pharmaceutical will receive exclusive rights to develop and commercialize ZERVIATE in South Korea, where the market for allergic conjunctivitis was worth nearly €31 million for the 12 months to Q3 2019.  
  • FDA Approves Zerviate drugs.com
    June 08, 2017
    Alkermes plc (NASDAQ: ALKS) today announced that the U.S. Food and Drug Administration (FDA) has approved two-month Aristada (aripiprazole lauroxil) extended-release injectable suspension for the treatment of schizophrenia.
  • FDA Approves Zerviate drugs.com
    June 07, 2017
    Nicox Receives FDA Approval of Zerviate (cetirizine ophthalmic solution) 0.24%

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service